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β-amino acids substituted at the 2 and 3 positions, named β2-and β3-amino acids, respectively, are very important chiral substructures found in natural products and active pharma-
ceutical ingredients (Fig. 1)1–3. In particular, the incorporation of 
β-amino acids into peptides allows modulation of their secondary 
structure and increase of their proteolytic stability, hence furnishing 
peptidomimetics with improved pharmacological value4,5. Although 
much progress has been made in the enantioselective synthesis of 
β-amino acids, more direct and versatile methods are still highly 
sought after3.
Migratory cross-couplings have emerged as interesting new 
methods to functionalize remote positions of alkyl chains and cyclic 
systems6–8. In particular, our group has shown that the use of appro-
priate ligands of palladium-based catalysts allows functionalization 
of various positions of the same reactant in a regiocontrolled fash-
ion through a Pd migration mechanism7. For instance, the Negishi 
coupling of racemic α-zincated Boc-piperidine, generated by Boc-
directed α-lithiation of Boc-piperidine 1 with s-BuLi/N,N,N’,N’-
tetramethylethylenediamine (TMEDA) and transmetallation to 
zinc, leads to the C2- and C3-arylated racemic products 2–3 with 
good positional selectivity in the presence of appropriate phosphine 
ligands L1–L2 (Fig. 2a)9. In principle, enantioselective versions of 
these one-pot reactions may be developed by using a chiral base in 
the initial lithiation step (selected enantioselective migratory cross-
couplings involving carbo- or hydropalladation of olefins are given 
in refs. 10–13). Indeed, in a seminal work, Campos and co-workers 
showed that the enantioselective lithiation of Boc-pyrrolidine 4 
in the presence of (–)-sp (sp represents sparteine)14, followed by 
one-pot Li–Zn transmetallation and Negishi coupling, furnished 
C2-arylated products 5 efficiently and with high enantioselectivi-
ties, reflecting the enantiospecific nature of the Li–Zn transmetal-
lation and cross-coupling steps (Fig. 2b)15. However, transposition 
to N-Boc-piperidine 1 was unsuccessful due to the lack of reactivity 
of the s-BuLi•sp complex towards this substrate16. O’Brien and co-
workers designed a less hindered surrogate of (+)-sp that provided 
enhanced reactivity in the lithiation step, but a modest yield and 
moderate enantioselectivity were observed in the Negishi aryla-
tion leading to product 6 (ref. 17). These precedents, together with 
unsuccessful attempts employing other enantioselective lithiations, 
discouraged us from developing an enantioselective C3-selective 
arylation of Boc-piperidine 1. Alternatively, we turned to Boc-1,3-
oxazinanes 7, which are protected forms of 3-aminopropanol, and 
hence very appealing substrates that could be used to develop a 
regiodivergent enantioselective functionalization strategy (Fig. 2c). 
The enantioselective lithiation of 7 with (–)-sp, which is currently 
unknown (the non-enantioselective α-lithiation of 2-methyl-Boc-
oxazinane with s-BuLi/TMEDA was reported in ref. 18; for the enan-
tioselective lithiation of a Boc-piperazine see ref. 19), would furnish 
α-lithiated intermediate A on deprotonation of the pro-S hydrogen 
atom14,16. Sequential transmetallations with ZnCl2 and the oxidative 
addition complex generated from Pd0/L and an electrophile R–X 
would afford complex B in a stereoretentive manner. In the pres-
ence of a bulky ligand such as L1 (see Fig. 2a), reductive elimina-
tion should be favoured to give the C4-functionalized product 8. 
In the presence of a less bulky and more conformationally flexible 
ligand such as L2(refs. 7,9), stereospecific Pd migration should occur 
from B, based on previous calculations9, via β-hydride elimina-
tion, providing complex C wherein Pd would remain bound to the 
same face of the molecule. π-bond rotation and migratory insertion 
would deliver complex D, which would undergo reductive elimina-
tion to give rise to the enantioenriched C5-functionalized product 
9. Isomers 8 and 9 would be simple precursors of β3-amino acid 10
and β2-amino acid 11, respectively, on aminal cleavage and oxida-
tion. Using (+)-sp (both enantiomers of sparteine are commercially 
available or readily prepared in multigram quantities from the seeds 
of Lupinus albus20) instead of (–)-sp in the initial lithiation step
would provide access to the enantiomeric end products ent-10 and
ent-11 through the same sequence.
Here we show that Boc-oxazinanes are lithiated efficiently and 
with high enantioselectivity using either stoichiometric or sub-
stoichiometric amounts of chiral base, and that the correspond-
ing organozinc compounds obtained on Li–Zn transmetallation 
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and C–H bonds for the β-H elimination step initiating Pd migra-
tion9. Moreover, the selectivity switch exerted by ligands L2–L3 can 
be explained by steric factors, that is, the steric environment of the 
phosphorus atom and the rotation around the C–N axis, according 
to previous studies9,21,26. Replacing TMEDA with (+)-sp provided 
1,3-oxazinane 9aa with a similar e.r. (77.5:22.5) to the one observed 
for the C4-arylated product 8aa (75:25, entry 2), showing that the 
migration occurs with high enantiospecificity. In this case, increas-
ing the bulk of the Z substituents (entries 9, 11 and 12) furnished an 
optimal yield for n-propyl groups (entry 11), together with a high 
enantioselectivity. Similar to the C5-selective arylation, the (+)-sp 
surrogate gave a slightly lower e.r. than (+)-sp (entry 10, compare 
with entry 9). Sparteine was kept for subsequent studies due to its 
lower price and the higher availability of both enantiomers.
Configuration and deuterium labelling. The absolute configu-
ration of the arylated 1,3-oxazinanes 8ab and 9ac obtained using 
(+)-sp was determined to be (S) after cleavage of the aminal and 
comparison of the specific rotations of the corresponding Boc-
aminoalcohols with literature data (see Supplementary References). 
In addition, quenching the organolithium intermediate obtained 
from 7c and (–)-sp with dimethyl sulfate followed by controlled 
aminal cleavage led to the known Boc-aminoalcohol 12 possess-
ing the opposite orientation of the methyl group and the (S) con-
figuration (Fig. 3a). This absolute configuration is expected from 
the sparteine-mediated enantioselective lithiations of other Boc-
amines, which always give the same induction sense14–17. In addi-
tion, the fact that the same sense of enantioselectivity is observed 
for compounds 12, 8ab and 9ac using a given enantiomer of sp 
confirms the expected stereoretentive nature of the various elemen-
tary steps depicted in Fig. 2c. Deuterium labelling experiments 
provided complementary insights (Fig. 3b). Performing the lithia-
tion of 7b and 7c with the s-BuLi•(–)-sp complex/trapping with 
CD3OD twice, as reported by Hoppe28, led to the deuterated 
1,3-oxazinanes 7b-D and 7c-D with 96% and 98% deuterium incor-
poration at the C4 position, respectively. Then, lithiating compound 
7b-D with the achiral s-BuLi•TMEDA complex and perform-
ing the C4-selective arylation under the same conditions as above 
furnished product 8ab-D with the same (S) absolute configura-
tion as 8ab obtained using (+)-sp, with the same deuterium con-
tent as 7b-D and an e.r. of 95:5. The latter matches the theoretical 
value calculated with an e.r. of 97:3 for the sp-mediated lithiation 
step and the 96% deuterium incorporation (see Supplementary 
Fig. 1). These values translate a very large kinetic isotope effect 
in the TMEDA-mediated lithiation. Similarly large kinetic iso-
tope effects (kH/kD > 30) were already reported by Hoppe28 and 
Beak29 for the lithiation of O- and N-carbamates, respectively, and 
were ascribed to the tunnel effect30. Performing the C5-selective 
arylation from 7c-D led to a similar outcome, with (S)-9ac-D 
being produced with a 97% deuterium content and an e.r. of 96:4. 
These results might be further exploited to synthesize isotopically-
labelled β-amino acids.
Scope of the C4 and C5 functionalization using stoichiometric 
sparteine. Using the optimal conditions, the scope of the C4 and 
C5 functionalization was next examined using (+)-sp as the chi-
ral diamine (Fig. 4; see also Supplementary Fig. 2). The C5 func-
tionalization (Fig. 4b) was found to be more general than the C4 
functionalization (Fig. 4a), as the latter was mainly limited to aryl 
and heteroaryl nonaflates bearing substituents at the para or meta 
positions. This is probably due to the fact that the C4 position is 
more sterically hindered than the C5. Nevertheless, this C4 aryla-
tion performed satisfyingly with a range of aryl nonaflates contain-
ing electronically diverse substituents at the para (8b–f) and meta 
(8g–i) positions. More substituted aryl groups were also compatible 
(8j,8k), as well as a naphthyl ring (8l) and diverse heteroaromatic 
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Fig. 1 | Examples of natural products and active pharmaceutical ingredients 
containing β2- and β3-amino acids.
undergo regiodivergent Negishi cross-coupling with nearly perfect 
ligand-controlled regioselectivity to give highly enantioenriched 
C4- and C5-functionalized products. The latter can be converted to 
valuable β2- and β3-amino acids on aminal cleavage and oxidation.
Results
Optimization of the reaction conditions. We began our studies 
by investigating the one-pot arylation of Boc-1,3-oxazinanes 7a–d 
containing various C2 substituents, which were easily synthesized 
in two steps from 3-aminopropanol and various ketones (Table 1; 
see also Supplementary Table 1). The lithiation of compound 7a 
with the achiral s-BuLi•TMEDA complex, followed by transmetal-
lation with ZnCl2 and cross-coupling with bromobenzene in the 
presence of the very bulky ligand L3, which we recently developed 
to avoid Pd migration in related Negishi couplings21, furnished the 
C4-arylated product 8aa exclusively in moderate yield (entry 1). 
Using (+)-sp instead of TMEDA in the lithiation step furnished a 
promising enantiomeric ratio (e.r.) of 75:25 (entry 2). Gratifyingly, 
replacing the methyl with ethyl groups on the oxazinane (7b) 
allowed an increase of the e.r. to 95:5 (entry 3). The less hindered 
(+)-sp surrogate (synthesized according to ref. 22) furnished a lower 
yield and enantioselectivity (entry 4). Further increasing the size of 
the Z groups was detrimental to the yield (entry 5). Finally, tun-
ing the conditions by replacing ZnCl2 with Zn(OAc)223, phenyl 
bromide with phenyl nonaflate21,24 and raising the cross-coupling 
temperature to 80 °C gave an improved efficiency (61%) and enan-
tioselectivity (e.r. 97:3, entry 6). Then, we switched the ligand of the 
cross-coupling step to the less hindered and conformationally more 
flexible phosphine L2, which was previously designed to favour the 
migratory coupling of Boc-piperidines9. Using substrate 7a and 
TMEDA in the lithiation step, the arylation site selectivity was 
completely switched to the C5 position, with no trace of C4 isomer 
(entry 7). This ligand-controlled, total switch of selectivity in favour 
of the migratory arylation is remarkable, since we always obtained 
mixtures of isomers during previous studies on migratory cou-
plings using an unbiased electrophile (for example, Fig. 2a)7,9,25–27.  
This behaviour might be related to the higher propensity of the 
1,3-oxazinane, as compared to the piperidine ring, to reach 
the twist-boat conformation required for the alignment of the 
C–Pd 
systems (8m–p). In all cases, similar results were obtained, with 
yields in the range of 45–71% and excellent e.r. values (95:5 to 97:3) 
for the (S) enantiomers. As expected, simply using (–)-sp instead 
of (+)-sp in the lithiation step afforded the (R) enantiomers of 8c, 
8f, 8j and 8l with similar levels of efficiency and enantioselectivity, 
demonstrating the enantiodivergent character of this method.
As mentioned above, the scope of the C5 functionalization 
was found to be broader than the C4 functionalization (Fig. 4b). 
In addition to para (9b–h) and meta (9i,9j)-substituted aryl bro-
mides, ortho-substituted aryl bromides could be employed (9k,9l). 
However, for product 9l bearing a strong electron-withdrawing CF3 
group, ligand L4 (DavePhos)31 afforded an improved efficiency, as 
previously observed with Boc-piperidines9. Disubstituted arenes 
(9m,9n), a naphthalene (9o) and heteroarenes (9p–r) could be 
employed with similar levels of efficiency and enantioselectivity. 
Surprisingly, an approximately 3:1 mixture of the C5 and C6 iso-
mers was isolated using 3-bromopyridine (see 9p). The C6 isomer 
was not detected in other cases, and the reason for this singularity 
is unclear at this point. In addition to (hetero)aryl bromides, alke-
nyl bromides also reacted successfully, as illustrated with products 
9s–v. Once again, good yields and high enantioselectivities (e.r. 92:8 
to 96:4) were achieved across all examples, and the correspond-
ing products are potential precursors of β2-amino acids containing 
a range of useful functional groups on further transformation of 
the alkene. In addition, similar to C4 functionalization, the use of 
(–)-sp afforded the (R) enantiomers of products 9ac, 9e, 9h, 9j, 9n, 
9o, 9r and 9v with similarly good yields and enantioselectivities. 
Finally, the reaction leading to product (R)-9e could be conducted 
on a gram scale with similar efficiency and enantioselectivity. 
Importantly, a simple aqueous extraction allowed recovery of 85% 
of the engaged (–)-sp.
Development of a catalytic enantioselective version. Next, we 
turned to the development of a catalytic enantioselective version 
of this method via the diamine exchange method (Fig. 5). Indeed, 
O’Brien and co-workers reported the enantioselective deproton-
ation of Boc-pyrrolidine using a combination of substoichiometric 
(–)-sp or (+)-sp surrogate and stoichiometric diisopropylbispidine, 
which is an achiral diamine that reacts slowly in the lithiation with 
s-BuLi but is able to exchange with the chiral diamine on the lithi-
ated intermediate32,33. Different chiral diamines (0.3 equivalent
(equiv.)) were first tested in combination with diisopropylbispidine
(1.3 equiv.) in the C5-arylation providing (S)-9c, and consistent
with O’Brien’s results the (+)-sp surrogate provided the best yield,
together with a satisfying e.r. of 93:7. As a comparison, compound
9c was obtained with 18% yield and 95:5 e.r. using (+)-sp instead
of the (+)-sp surrogate in combination with diisopropylbispidine,
which probably indicates that (+)-sp is not easily displaced by diiso-
propylbispidine, unlike the (+)-sp surrogate. It should be noted
that both enantiomers of the sparteine surrogate are in principle
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although generally lower than those obtained with stoichiometric 
(+)-sp (compare to Fig. 4). Indeed, the enantioselectivity induced 
by the (+)-sp surrogate in the lithiation step is lower than (+)-sp 
(see Table 1). Nevertheless, these results represent a solid proof of 
concept showing the feasibility of catalytic enantioselective diver-
gent functionalization.
Application to the synthesis of β2- and β3-amino acids. To achieve 
our initial goal, we finally studied the transformation of selected C4- 
and C5-functionalized 1,3-oxazinanes into β2- and β3-amino acids 
(Fig. 6). A simple treatment with trifluoroacetic acid (TFA) in THF 
effected the cleavage of the aminal group to give the corresponding 
N-Boc-1,3-aminoalcohols, which are valuable chiral intermediates
for asymmetric synthesis in their own right35. Then, two one-step
procedures were employed for their oxidation to the corresponding
β-amino acids. Sharpless’ oxidation was employed for the less sensi-
tive aminoalcohols (method A)36, whereas the method employing
catalytic 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) and stoi-
chiometric (diacetoxyiodo)benzene (PIDA) was preferred for more
sensitive ones (method B)37. Selected functionalized oxazinanes 8–9
were hence converted to over 20 valuable β2- and β3-amino acids
10–11, most of them being new, bearing (hetero)aryl or alkenyl
substituents in good yield and excellent enantiospecificity, thereby
preserving the enantioselectivity achieved in the initial lithiation
step. Notably, the racemization of the more sensitive β2-amino
acids 11 was not observed under these conditions. Both (R) and
(S) enantiomers of the β-amino acids are accessible through this
method by simply changing the sparteine enantiomer in the lithia-
tion step of the overall sequence. The X-ray diffraction analysis
of product 11a obtained using (–)-sp confirmed the absolute con-
figurations deduced from the comparison of specific rotations of
the known β-aminoalcohols (12, precursors of 10c and 10l) and
acids (10a, 10e and 11a) synthesized in this study with the corre-
sponding literature values. Of note, compound (R)-10c is a potential 
Table 1 | effect of selected parameters on the arylation of Boc-1,3-oxazinanes
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1d Me 7a TMEDA L3 >98:2 8aa 54 –
2d Me 7a (+)-sp L3 >98:2 8aa 53 75:25
3d Et 7b (+)-sp L3 >98:2 8ab 51 95:5
4d Et 7b (+)-sp surrogate L3 >98:2 8ab 46 91:9
5d n-Pr 7c (+)-sp L3 >98:2 8ac 30 94:6
6e,f Et 7b (+)-sp L3 >98:2 8ab 61 97:3
7 Me 7a TMEDA L2 <2:98 9aa 65 –
8 Me 7a (+)-sp L2 <2:98 9aa 51 77.5:22.5
9 Et 7b (+)-sp L2 <2:98 9ab 48 97:3
10 Et 7b (+)-sp surrogate L2 <2:98 9ab 89 94:6
11f n-Pr 7c (+)-sp L2 <2:98 9ac 72 96.5:3.5
12 –(CH2)4– 7d (+)-sp L2 <2:98 9ad 23 85:15
Reaction conditions unless otherwise stated: 7 (1.0 equiv.), s-BuLi (1.2 equiv.), diamine (1.2 equiv.), Et2O, –78 °C, 8 h, then ZnCl2/tetrahydrofuran (THF) (1.2 equiv.), –78→20 °C, 1 h, then removal of volatiles, 
then PhBr (0.7 equiv), Pd2dba3 (2.5 mol%), ligand (5 mol%), toluene, 80 °C, 17–24 h. aMeasured by gas chromatography–mass spectrometry or 1H nuclear magnetic resonance (NMR) analysis of the crude 
reaction mixture. bYield of the isolated product. cDetermined by high performance liquid chromatography (HPLC) on a chiral stationary phase. dCross-coupling step performed at 60 °C instead of 80 °C. 
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accessible, and hence this catalytic version can also be applied to 
synthesize both enantiomers of β-amino acids34. These conditions 
were applied to both C4- and C5-selective arylations with a few aryl 
electrophiles. The yields and enantioselectivities were 
satisfying, 
precursor of the β3-amino acid found in jasplakinolide (Fig. 1), on 
cleavage of the methoxy group. Similarly, compound (S)-11e is a 
potential precursor of the β2-amino acid found in netarsudil on 
reduction of the carboxylic ester. These two examples further illus-
trate the interest of the current methodology for the synthesis of 
bioactive molecules.
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Conclusion
Boc-1,3-oxazinanes are unique platforms for the selective functional-
ization at the C4 or C5 position using the one-pot directed lithiation, 
Li–Zn transmetallation and Negishi cross-coupling sequence. The 
regioselectivity of the cross-coupling step is totally ligand-controlled, 
and high enantioselectivities can be achieved for both C4 and C5 iso-
mers using a chiral diamine in the lithiation step, by taking advantage 
of the enantiospecific character of the subsequent steps. A simple two-
step transformation of the coupling products leads to enantioenriched 
β2- and β3-amino acids, which are important building blocks for the 
design of new pharmaceuticals and peptidomimetics.
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